Cutler Group LP Vbi Vaccines Inc Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$0.29 - $0.64 $87 - $192	-300 Reduced 20.0%	1,200 $0
Q2 2022 Aug 04, 2022	BUY	$0.66 - $1.81 $198 - $543	300 Added 25.0%	1,500 $1,000
Q2 2021 Jul 19, 2021	SELL	$2.61 - $4.17 $16,182 - $25,854	-6,200 Reduced 83.78%	1,200 $4,000
Q1 2021 Apr 26, 2021	BUY	$2.91 - $4.32 $20,079 - $29,808	6,900 Added 1380.0%	7,400 $23,000
Q4 2020 Jan 21, 2021	SELL	$2.15 - $3.5 $3,225 - $5,250	-1,500 Reduced 75.0%	500 $1,000
Q3 2020 Oct 27, 2020	SELL	$2.77 - $6.17 $831 - $1,851	-300 Reduced 13.04%	2,000 $5,000
Q2 2020 Jul 22, 2020	BUY	$0.87 - $3.13 $957 - $3,443	1,100 Added 91.67%	2,300 $7,000
Q1 2020 May 07, 2020	BUY	$0.73 - $1.91 $876 - $2,292	1,200 New	1,200 $1,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.